Folic acid in general medicine and dermatology
暂无分享,去创建一个
[1] M. Fava,et al. Nutrition and depression: the role of folate. , 2009, Nutrition reviews.
[2] P. Gisondi,et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis , 2006, The British journal of dermatology.
[3] J. Mann,et al. A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.
[4] A. Ilchyshyn,et al. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double‐blind, placebo‐controlled trial , 2006, The British journal of dermatology.
[5] A. Mangoni. Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials? , 2006, Clinica chimica acta; international journal of clinical chemistry.
[6] R. Zimmermann,et al. Folic acid: a public-health challenge , 2006, The Lancet.
[7] E. Rimm,et al. Folate supplementation and cardiovascular disease , 2006, The Lancet.
[8] Per Magne Ueland,et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.
[9] F. Meiss,et al. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. , 2006, European journal of dermatology : EJD.
[10] E. Ferrannini,et al. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects , 2006, International Journal of Obesity.
[11] Michael Hinckley,et al. Impact of obesity and smoking on psoriasis presentation and management. , 2005, Archives of dermatology.
[12] B. Lebowitz,et al. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. , 2005, The international journal of neuropsychopharmacology.
[13] S. Ebrahim,et al. Folate supplementation and cardiovascular disease , 2005, The Lancet.
[14] B. Strober,et al. Folate supplementation during methotrexate therapy for patients with psoriasis. , 2005, Journal of the American Academy of Dermatology.
[15] M. Landray,et al. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. , 2005, The American journal of clinical nutrition.
[16] W. Willett,et al. Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status , 2005, Cancer Epidemiology Biomarkers & Prevention.
[17] L. Naldi,et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.
[18] I. Mcdowell,et al. Homocysteine and endothelial function in human studies. , 2005, Seminars in vascular medicine.
[19] L. Bailey,et al. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. , 2005, The American journal of clinical nutrition.
[20] G. Davey Smith,et al. Taking folate in pregnancy and risk of maternal breast cancer , 2005, BMJ : British Medical Journal.
[21] Mark Lucock,et al. Folic acid — vitamin and panacea or genetic time bomb? , 2005, Nature Reviews Genetics.
[22] M. Boffa,et al. Methotrexate for psoriasis: current European practice. A postal survey , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.
[23] S. Feldman,et al. The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.
[24] U. Hoffmann,et al. Mild hyperhomocysteinemia: risk factor or just risk predictor for cardiovascular diseases? , 2004, VASA. Zeitschrift fur Gefasskrankheiten.
[25] H. Suryapranata,et al. Folate therapy and in-stent restenosis after coronary stenting. , 2004, The New England journal of medicine.
[26] G. Goodwin,et al. Folate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2004, Journal of psychopharmacology.
[27] J. Severens,et al. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. , 2004, The Journal of rheumatology.
[28] J. Erickson,et al. Vitamin supplements and the risk for congenital anomalies other than neural tube defects , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.
[29] K. Svärdsudd,et al. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population‐based study , 2003, Journal of internal medicine.
[30] A. Gottlieb,et al. Connections between psoriasis and Crohn's disease. , 2003, Journal of the American Academy of Dermatology.
[31] A. Alver,et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[32] F. Granath,et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.
[33] Hiroyuki Suzuki,et al. Sequence-specific DNA damage induced by ultraviolet A-irradiated folic acid via its photolysis product. , 2003, Archives of biochemistry and biophysics.
[34] H. McNulty,et al. The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet. , 2002, The British journal of nutrition.
[35] Per Magne Ueland,et al. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.
[36] G. Girolomoni,et al. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. , 2002, European journal of dermatology : EJD.
[37] M. Law,et al. Quantifying the effect of folic acid , 2001, The Lancet.
[38] J. Lüthy,et al. Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. , 2001, Swiss medical weekly.
[39] R. Harbour,et al. A new system for grading recommendations in evidence based guidelines , 2001, BMJ : British Medical Journal.
[40] P. Jacques,et al. Power Shortage: Clinical Trials Testing the Homocysteine Hypothesis against a Background of Folic AcidFortified Cereal Grain Flour , 2001, Annals of Internal Medicine.
[41] B. Dijkmans,et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. , 2001, Arthritis and rheumatism.
[42] M. Lucock,et al. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. , 2000, Molecular genetics and metabolism.
[43] F. D'armiento,et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. , 2000, The Journal of rheumatology.
[44] Y. Kim,et al. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. , 1999, Nutrition reviews.
[45] I. Rosenberg,et al. Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (19911994): Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations , 1999, Annals of Internal Medicine.
[46] G A Colditz,et al. A prospective study of folate intake and the risk of breast cancer. , 1999, JAMA.
[47] H. Blom,et al. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.
[48] J. Manson,et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.
[49] S. Vollset,et al. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.
[50] L. Juhlin,et al. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. , 1997, Acta dermato-venereologica.
[51] E. Rimm,et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.
[52] A. Wahba-Yahav. Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.
[53] N R Campbell,et al. How safe are folic acid supplements? , 1996, Archives of internal medicine.
[54] M. De Vos,et al. Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. , 1995, The Journal of rheumatology.
[55] L. Montes,et al. Folic acid and vitamin B12 in vitiligo: a nutritional approach. , 1992, Cutis.
[56] D. M. Hoffman,et al. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. , 1991, Annals of the rheumatic diseases.
[57] J. Culebras,et al. [Folates in human nutrition, Different clinical situations in which folate deficiencies exist]. , 1991, Nutricion hospitalaria.
[58] S. Young,et al. Folic acid and psychopathology , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[59] C. Halsted. The intestinal absorption of dietary folates in health and disease. , 1989, Journal of the American College of Nutrition.
[60] R. Russell,et al. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. , 1988, The Journal of laboratory and clinical medicine.
[61] J. Pincus,et al. Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate. , 1971, The Journal of clinical investigation.
[62] L. Fry,et al. THE MECHANISM OF FOLATE DEFICIENCY IN PSORIASIS , 1971, The British journal of dermatology.
[63] M. Righetti. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients , 2007, Clinical chemistry and laboratory medicine.
[64] Richard Gordon,et al. A hypothesis linking low folate intake to neural tube defects due to failure of post-translation methylations of the cytoskeleton. , 2006, The International journal of developmental biology.
[65] A. A. Liakishev. [Homocysteine lowering with folic acid and B vitamins in vascular disease]. , 2006, Kardiologiia.
[66] F. Trivin,et al. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. , 2006, Clinical chemistry.
[67] J. Callen,et al. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. , 2006, Archives of dermatology.
[68] K. Hamulýak,et al. Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis. , 2002, Acta dermato-venereologica.
[69] L Juhlin,et al. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. , 2002, Acta dermato-venereologica.
[70] I. Rebelo,et al. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[71] W. Willett,et al. Diet and coronary heart disease: findings from the Nurses' Health Study and Health Professionals' Follow-up Study. , 2001, The journal of nutrition, health & aging.
[72] R. Matthews,et al. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia , 1999, Nature Structural Biology.
[73] H. Hoffman,et al. Serum concentrations of zinc, folate, vitamins A and E, and proteins, and their relationships to pregnancy outcome. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.
[74] P. Frosst,et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.
[75] N. Geller,et al. Systemic absorption of a leucovorin mouth wash: a pharmacologic study. , 1987, Cancer investigation.
[76] D. Hild. Folate losses from the skin in exfoliative dermatitis. , 1969, Archives of internal medicine.